Syngenta Group CEO Jeff Rowe is optimistic that research and development investments made over the last decade, totaling about $611 million in the U.S. alone, position the company for stronger future growth.
To view this article, please
login. If you are not a current subscriber, you may sign up for a trial or view other subscription options
here.
